Paul Joyce on Muck Rack

Paul Joyce

Verified
United Kingdom
As seen in: The Times, MSN, Color Research & Application, Nature, The Guardian, The Washington Post, Yahoo Canada, Daily Express, Hubspot Blog, Barnes and Noble, Manawatū Standard and
Northern Football Correspondent for The Times
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GLP‑1 drugs like Ozempic show promise for more than weight loss, but what's science vs. hype?

|
By Paul Joyce , Lisa Lock, Andrew Zinin 
| Medical Xpress
Credit: Unsplash/CC0 Public Domain You've probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes. Now, researchers are investigating whether these medications known as GLP-1 agonists or GLP-1 drugs could treat everything from cancer and brain disease to depression, addiction and endometriosis. Some findings are genuinely exciting. Others are being oversold. Here's what the science actually says. First, how do these drugs work?
Open in Who Shared Issue with article?

GLP‑1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype?

|
By Paul Joyce 
| The Conversation
You’ve probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes. Now, researchers are investigating whether these medications known as GLP-1 agonists or GLP-1 drugs could treat everything from cancer and brain disease to depression, addiction and endometriosis. Some findings are genuinely exciting. Others are being oversold. Here’s what the science actually says. First, how do these drugs work?
Open in Who Shared View Duplicates (5) Issue with article?

The Post

|
By Paul Joyce 
| The Post (Wellington)
Open in Who Shared Issue with article?
See all 438 licensed articles (510 Total)

Actions

Share this page

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified